Peer-reviewed journal articles (57)
49.
Colli, M. L., Moore, F., Gurzov, E. N., Ortis, F., & Eizirik, D. L. (2010). MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. Human molecular genetics, 19(1), 135-146. doi:10.1093/hmg/ddp47450.
Andrade Da Cunha, D., Ladrière, L., Ortis, F., Igoillo Esteve, M., Gurzov, E. N., Lupi, R., Marchetti, P., Eizirik, D., & Cnop, M. (2009). Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes (New York, N.Y.), 58(12), 2851-2862. doi:10.2337/db09-068551.
Gurzov, E. N., Ortis, F., Andrade Da Cunha, D., Gosset, G., Li, M., Cardozo, A. K., & Eizirik, D. L. (2009). Signaling by IL-1beta+IFN-gamma and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic beta-cell apoptosis. Cell death and differentiation, 16(11), 1539-1550. doi:10.1038/cdd.2009.9952.
Gurzov, E. N., Ortis, F., Bakiri, L., Wagner, E. F., & Eizirik, D. L. (2008). JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells. PloS one, 3(8), e3030. doi:10.1371/journal.pone.000303053.
Gurzov, E. N., Bakiri, L., Alfaro, J. M., Wagner, E. F., & Izquierdo, M. (2008). Targeting c-Jun and JunB proteins as potential anticancer cell therapy. Oncogene, 27(5), 641-652. doi:10.1038/sj.onc.121069054.
Gurzov, E. N., Nabha, S. S., Yamamoto, H., Meng, H., Scharovsky, G. O., & Bonfil, D. R. (2007). Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell line. BMC cancer, 7, 184. doi:10.1186/1471-2407-7-18456.
Pastrana, E., Moreno-Flores, M. T., Gurzov, E. N., Avila, J., Wandosell, F., & Diaz-Nido, J. (2006). Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. The Journal of neuroscience, 26(20), 5347-5359. doi:10.1523/JNEUROSCI.1111-06.2006 Papers published in national and international conferences or symposium proceedings (8)
1.
Takiishi, T., Xiao, P., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2022). Pancreatic beta cells are resistant to RIPK1 kinase-mediated death. Diabetologia,(vol. 65, p. 211). doi:10.1007/s00125-022-05755-w2.
Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Demine, S., Xiao, P., Cardozo, A. K., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2022). Single-cell sequencing reveals preserved pancreatic islet cell identity by administration of metabolite-based diet in autoimmune diabetes. Diabetologia, Vol. 65 , 211. doi:10.1007/s00125-022-05755-w3.
Brahma, M. K., Xiao, P., Popa, M., Vandenbempt, V., Negueruela Escudero, J., Cardozo, A. K., & Gurzov, E. N. (2021). The Nova1-Bim axis in pancreatic beta-cells does not impact glucose homeostasis in obesity and multiple low-dose streptozotocin-induced diabetes. Diabetologia,(64 (Suppl 1):S1–S380). doi:10.1007/s00125-021-05519-y